135 related articles for article (PubMed ID: 16682383)
1. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study.
Kardys I; de Maat MP; Uitterlinden AG; Hofman A; Witteman JC
Eur Heart J; 2006 Jun; 27(11):1331-7. PubMed ID: 16682383
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study.
Kardys I; Uitterlinden AG; Hofman A; Witteman JC; de Maat MP
Thromb Haemost; 2007 Feb; 97(2):288-95. PubMed ID: 17264959
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms and haplotypes in the C-reactive protein gene and risk of dementia.
van Oijen M; de Maat MP; Kardys I; de Jong FJ; Hofman A; Koudstaal PJ; Witteman JC; Breteler MM
Neurobiol Aging; 2007 Sep; 28(9):1361-6. PubMed ID: 16854501
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and risk of heart failure. The Rotterdam Study.
Kardys I; Knetsch AM; Bleumink GS; Deckers JW; Hofman A; Stricker BH; Witteman JC
Am Heart J; 2006 Sep; 152(3):514-20. PubMed ID: 16923423
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis.
Sie MP; Sayed-Tabatabaei FA; Oei HH; Uitterlinden AG; Pols HA; Hofman A; van Duijn CM; Witteman JC
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):212-7. PubMed ID: 16269662
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor gene and risk of cardiovascular disease.
van den Akker EL; Koper JW; van Rossum EF; Dekker MJ; Russcher H; de Jong FH; Uitterlinden AG; Hofman A; Pols HA; Witteman JC; Lamberts SW
Arch Intern Med; 2008 Jan; 168(1):33-9. PubMed ID: 18195193
[TBL] [Abstract][Full Text] [Related]
8. Haplotypes of the NR4A2/NURR1 gene and cardiovascular disease: the Rotterdam Study.
Kardys I; van Tiel CM; de Vries CJ; Pannekoek H; Uitterlinden AG; Hofman A; Witteman JC; de Maat MP
Hum Mutat; 2009 Mar; 30(3):417-23. PubMed ID: 19156841
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation, C-reactive protein levels, and incidence of diabetes.
Dehghan A; Kardys I; de Maat MP; Uitterlinden AG; Sijbrands EJ; Bootsma AH; Stijnen T; Hofman A; Schram MT; Witteman JC
Diabetes; 2007 Mar; 56(3):872-8. PubMed ID: 17327459
[TBL] [Abstract][Full Text] [Related]
10. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study.
Kardys I; Klaver CC; Despriet DD; Bergen AA; Uitterlinden AG; Hofman A; Oostra BA; Van Duijn CM; de Jong PT; Witteman JC
J Am Coll Cardiol; 2006 Apr; 47(8):1568-75. PubMed ID: 16630992
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study).
Kardys I; de Maat MP; Klaver CC; Despriet DD; Uitterlinden AG; Hofman A; de Jong PT; Witteman JC
Am J Cardiol; 2007 Aug; 100(4):646-8. PubMed ID: 17697822
[TBL] [Abstract][Full Text] [Related]
12. Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke.
den Hertog HM; van den Herik EG; Dippel DW; Koudstaal PJ; de Maat MP
Cerebrovasc Dis; 2010; 29(4):372-5. PubMed ID: 20145391
[TBL] [Abstract][Full Text] [Related]
13. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study.
Bos MJ; Schipper CM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
Circulation; 2006 Oct; 114(15):1591-8. PubMed ID: 17015791
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.
van Durme YM; Verhamme KM; Aarnoudse AJ; Van Pottelberge GR; Hofman A; Witteman JC; Joos GF; Brusselle GG; Stricker BH
Am J Respir Crit Care Med; 2009 Mar; 179(5):375-82. PubMed ID: 19096002
[TBL] [Abstract][Full Text] [Related]
16. Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia.
Suk Danik J; Chasman DI; Cannon CP; Miller DT; Zee RY; Kozlowski P; Kwiatkowski DJ; Ridker PM
Ann Hum Genet; 2006 Nov; 70(Pt 6):705-16. PubMed ID: 17044845
[TBL] [Abstract][Full Text] [Related]
17. Allelic variation at the C-reactive protein gene associates to both hand osteoarthritis severity and serum high sensitive C-reactive protein levels in the GARP study.
Bos SD; Suchiman HE; Kloppenburg M; Houwing-Duistermaat JJ; le Graverand MP; Seymour AB; Kroon HM; Slagboom PE; Meulenbelt I
Ann Rheum Dis; 2008 Jun; 67(6):877-9. PubMed ID: 18055473
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia.
Hung J; Knuiman MW; Divitini ML; Langton PE; Chapman CL; Beilby JP
Heart Lung Circ; 2008 Apr; 17(2):90-5. PubMed ID: 17851127
[TBL] [Abstract][Full Text] [Related]
19. Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk.
Hingorani AD; Shah T; Casas JP
Eur Heart J; 2006 Jun; 27(11):1261-3. PubMed ID: 16684780
[No Abstract] [Full Text] [Related]
20. Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study.
van Vark LC; Kardys I; Bleumink GS; Knetsch AM; Deckers JW; Hofman A; Stricker BH; Witteman JC
Eur Heart J; 2006 Oct; 27(19):2346-52. PubMed ID: 16952920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
